US FDA declines to approve Summit lung cancer drug after trial misses key survival goal – Reuters

📅 Published: November 15, 2026 | 📂 Category: English

US FDA declines to approve Summit lung cancer drug after trial misses key survival goal  Reuters


📱 Share on WhatsApp 🌐 View Original Article

Leave a Reply

Your email address will not be published. Required fields are marked *